Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Fraser Symmans

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2021
Interpreting the Complex Landscape of Immune-Tumor InterfaceW Fraser Symmans
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Genomic testing for sensitivity of breast cancer to hormonal therapyW Fraser Symmans
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Translational research in the National Cancer Institute's cooperative groupsW Fraser Symmans
Oncology (Williston Park, N.Y.)|June 5, 2012
A perspective on genomic tests for breast cancer: the need for progressW Fraser Symmans
Seminars in Oncology|May 22, 2007
A pathologist's perspective on emerging genomic tests for breast cancerW Fraser Symmans
Annals of Surgical Oncology|July 7, 2016
Standardizing of Pathology in Patients Receiving Neoadjuvant ChemotherapyVeerle Bossuyt, W Fraser Symmans
Annals of Surgical Oncology|March 15, 2008
Fingerprinting lymph node metastasesW Fraser Symmans, Gabriel N Hortobagyi
Pharmacogenomics|November 6, 2007
Gene-expression microarrays provide new prognostic and predictive tests for breast cancerYun Gong, W Fraser Symmans, Lajos Pusztai
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
CCR 20th Anniversary Commentary: Divide and Conquer-Breast Cancer Subtypes and Response to TherapyLajos Pusztai, Roman Rouzier, W Fraser Symmans
JAMA Oncology|February 24, 2022
Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-ReplyRita Mukhtar, W Fraser Symmans, Laura J Esserman
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 14, 2021
Interpreting the Complex Landscape of Immune-Tumor InterfaceW Fraser Symmans
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Genomic testing for sensitivity of breast cancer to hormonal therapyW Fraser Symmans
Clinical Advances in Hematology & Oncology : H&O|February 13, 2015
Translational research in the National Cancer Institute's cooperative groupsW Fraser Symmans
Oncology (Williston Park, N.Y.)|June 5, 2012
A perspective on genomic tests for breast cancer: the need for progressW Fraser Symmans
Seminars in Oncology|May 22, 2007
A pathologist's perspective on emerging genomic tests for breast cancerW Fraser Symmans
Annals of Surgical Oncology|July 7, 2016
Standardizing of Pathology in Patients Receiving Neoadjuvant ChemotherapyVeerle Bossuyt, W Fraser Symmans
Annals of Surgical Oncology|March 15, 2008
Fingerprinting lymph node metastasesW Fraser Symmans, Gabriel N Hortobagyi
Pharmacogenomics|November 6, 2007
Gene-expression microarrays provide new prognostic and predictive tests for breast cancerYun Gong, W Fraser Symmans, Lajos Pusztai
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 16, 2015
CCR 20th Anniversary Commentary: Divide and Conquer-Breast Cancer Subtypes and Response to TherapyLajos Pusztai, Roman Rouzier, W Fraser Symmans
JAMA Oncology|February 24, 2022
Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer-ReplyRita Mukhtar, W Fraser Symmans, Laura J Esserman
Pageof 24